Clinical Trials on Triple-negative Breast Cancer in Finland
Total 305 results
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | HER2/Neu Negative | Breast Adenocarcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States, South Africa
-
Tampere University HospitalTurku University Hospital; Kuopio University Hospital; Jyväskylä Central HospitalActive, not recruitingQuality of Life | Breast Cancer | Patient Satisfaction | Multidisciplinary Communication | Resection Margin | Surgical MarginFinland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic Stage II Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Hormone Receptor... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
Tampere University HospitalUniversity of Turku; University of Helsinki; Tampere University; Aalto UniversityRecruitingKidney Cancer | Breast Cancer | Metastatic Renal Cell Carcinoma | Ovarian Cancer | Prostate Cancer | Metastatic Breast Cancer | Metastatic Prostate Cancer | Metastatic Prostate Adenocarcinoma | Metastatic Ovarian Cancer | Metastatic Renal Cancer | Metastatic Kidney Cancer | Metastatic Ovary CancerFinland
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Elevated CA15-3 or CEA or CA27-29United States, Puerto Rico, Guam
-
Regional Oncologic CenterEuropean Organisation for Research and Treatment of Cancer - EORTC; Scandinavian... and other collaboratorsCompletedBreast Cancer | Menopausal SymptomsFinland, Norway, Poland, Sweden, Switzerland
-
Dana-Farber Cancer InstituteNanoString Technologies, Inc.Active, not recruiting
-
Hoffmann-La RocheRecruitingBreast CancerFinland, Germany, Italy
-
Karolinska InstitutetRecruitingBreast CancerSweden, Finland, Australia, United Kingdom
-
Brown UniversityThe Miriam Hospital; Rhode Island Hospital; Women and Infants Hospital of Rhode...CompletedBreast CancerUnited States
-
Roger Williams Medical CenterWithdrawnBreast CancerUnited States
-
The Miriam HospitalAmerican Cancer Society, Inc.UnknownBreast CancerUnited States
-
Rhode Island HospitalCompleted
-
Roger Williams Medical CenterSuspendedBreast CancerUnited States
-
Brown UniversityThe Miriam Hospital; Rhode Island Hospital; Memorial Hospital of Rhode Island; Women... and other collaboratorsTerminatedTrial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for RelapseBreast CancerUnited States
-
Side-Out FoundationTranslational Drug DevelopmentCompleted
-
Allarity TherapeuticsRecruitingMetastatic Breast CancerFinland, Poland, Germany, United Kingdom, Belgium, Italy, Netherlands
-
William Sikov MDYale UniversityCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteSusan G. Komen Breast Cancer FoundationRecruiting
-
Jaroslaw HepelThe Miriam Hospital; Rhode Island HospitalCompletedBreast CancerUnited States
-
William Sikov MDYale UniversityCompletedBreast CancerUnited States
-
Volastra Therapeutics, Inc.RecruitingGastric Adenocarcinoma | Uterine Carcinosarcoma | Triple Negative Breast Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma | Esophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Transitional Cell Carcinoma of Bladder | Colorectal Adenocarcinoma | Gastroesophageal Junction... and other conditionsUnited States
-
Cancer Trials IrelandCompletedMetastatic Breast CancerSpain, Ireland, Israel, Finland, Portugal, France, Germany, Norway
-
Hoffmann-La RocheCompletedBreast CancerAustralia, Spain, United Kingdom, Germany, Belgium, Italy, Finland, Netherlands
-
The Miriam HospitalBrown UniversityCompleted
-
Women and Infants Hospital of Rhode IslandCompletedBreast Cancer | Hot FlashesUnited States
-
BayerCompletedMetastatic Breast CancerSpain, Austria, United Kingdom, France, Finland, Poland, Germany, Sweden, Italy, Switzerland
-
University of New BrunswickQuebec Breast Cancer Foundation; UltramarUnknown
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Gilead SciencesRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Metastatic Malignant Neoplasm in the Brain | Metastatic HER2 Negative Breast CarcinomaUnited States
-
Celgene CorporationWithdrawnMetastatic Breast CancerUnited States
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
CairnSurgical, Inc.SuspendedBreast Cancer FemaleUnited States, Canada, United Kingdom
-
Dana-Farber Cancer InstitutePfizerActive, not recruitingBreast CancerUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States, Canada, Finland, France, Italy, Spain, Taiwan, United Kingdom
-
NCIC Clinical Trials GroupCompletedBreast CancerUnited States, Canada
-
Enzon Pharmaceuticals, Inc.TerminatedMetastatic Breast CancerUnited States
-
Dilon Medical Technologies Ltd.Recruiting
-
Provista Diagnostics, IncUnknownBreast CancerUnited States
-
Northwestern UniversityCompletedBreast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | HER2/Neu PositiveUnited States, Puerto Rico
-
Dana-Farber Cancer InstitutePatient-Centered Outcomes Research InstituteActive, not recruiting
-
Tragara Pharmaceuticals, Inc.Terminated
-
Yale UniversityActive, not recruitingBreast CancerUnited States
-
Brown UniversityUniversity of California, San Diego; Cancer Treatment Centers of America; Watson...CompletedBreast CancerUnited States
-
Sanarus Technologies, Inc.RecruitingBreast CancerUnited States
-
Veru Inc.WithdrawnMetastatic Breast CancerUnited States
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
NSABP Foundation IncPuma Biotechnology, Inc.Completed
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States